[Federal Register Volume 90, Number 188 (Wednesday, October 1, 2025)]
[Notices]
[Page 47315]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-19108]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Secretary; Notice of Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Muscular Dystrophy 
Coordinating Committee (MDCC).
    The meeting will be held as an online meeting and will be open to 
the public. Individuals who need special assistance or other reasonable 
accommodation should notify the Contact Person listed below in advance 
of the meeting. Information for online viewing is provided below.

    Name of Committee: Muscular Dystrophy Coordinating Committee.
    Date: October 31, 2025.
    Time: 12:00 p.m. to 4:00 p.m. ET.
    Agenda: The purpose of this meeting is to bring together 
committee members, representing government agencies, patient 
advocacy groups and people with lived experience to discuss topics 
of interest to the muscular dystrophy communities. The agenda for 
this meeting features panel discussions inviting industry leaders to 
comment on priorities for the Action Plan, the MDCC's ten-year 
strategic plan for research and other strategies to improve the 
lives of people living with muscular dystrophies. The agenda for 
this meeting is available on the registration site below and the 
MDCC website: https://www.mdcc.nih.gov/.
    Address: National Institutes of Health, National Institutes of 
Health (NIH), 9000 Rockville Pike, Bethesda, Maryland 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Glen Nuckolls, Ph.D., National Institute of 
Neurological Disorders and Stroke (NINDS), NIH, 6001 Executive Blvd. 
Bethesda, MD 20892, 301-496-5876, [email protected].

    Registration: Registration is required to view the webcast. 
Registration information is available at https://events.gcc.teams.microsoft.com/event/1e491494-396e-42b7-874c-ecf6f85e45dc@14b77578-9773-42d5-8507-251ca2dc2b06.
    Any interested person may file written comments with the 
committee by sending a statement to the Contact Person listed on 
this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Anyone from the public can register for a link to view the 
meeting and submit questions, and the meeting can be viewed via the 
NIH Videocasting website (http://videocast.nih.gov). Please check 
the registration website or the committee website listed below for 
the most up-to-date information about this meeting.
    More information can be found on the Muscular Dystrophy 
Coordinating Committee website: https://mdcc.nih.gov/.

    Dated: September 26, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee 
Policy.
[FR Doc. 2025-19108 Filed 9-30-25; 8:45 am]
BILLING CODE 4140-01-P